Publications: Haemophilus influenzae

2000 to Present:

• Hu F, Rishishwar L, Sivadas A, et al. Comparative genomic analysis of Haemophilus haemolyticus and non-typeable Haemophilus influenzae and a new testing scheme for their discrimination. J Clin Microbiol. 2016;54(12):3010-7.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2014.
• Blain A, MacNeil J, Wang X, et al. Invasive Haemophilus influenzae disease in adults ≥65 years, United States, 2011. Open Forum Infect Dis. 2014;1(2):ofu044.
• Briere EC, Rubin L, Moro PL, Cohn A, Clark T, Messonnier N. Prevention and control of Haemophilus influenzae type b disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63(RR01):1-14.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2013[1 page].
• Anderson R, Wang X, Briere EC, et al. Haemophilus haemolyticus isolates causing clinical disease. J Clin Microbiol. 2012;50(7): 2462-5.
• Briere EC, Jackson M, Shah SG, et al. Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998-2009. Pediatrics. 2012;130(3):414-20.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2012[1 page].
• Jackson ML, Rose CE, Cohn A, et al. Modeling insights into Haemophilus influenzae type b disease, transmission, and vaccine programs. Emerg Infect Dis. 2012;18:13-20.
• Livorsi DJ, MacNeil JR, Cohn AC, et al. Invasive Haemophilus influenzae in the United States, 1999-2008: Epidemiology and outcomes. J Infect. 2012;65(6):496-504.
• Lowther SA, Shinoda N, Juni BA, et al. Haemophilus influenzae type b infection, vaccination, and influenzae carriage in children in Minnesota, 2008-2009. Epidemiol Infect. 2012;140(3):566-74.
• Theodore MJ, Anderson RD, Wang X, et al. Evaluation of new biomarker genes for differentiating Haemophilus influenzae from Haemophilus haemolyticus. J Clin Microbiol. 2012;50(4):1422-24.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2011[1 page].
• Jordan IK, Conley AB, Antonov IV, et al. Genome sequences for five strains of the emerging pathogen Haemophilus haemolyticus. J Bacteriol. 2011;193:5879-5880.
• MacNeil JR, Cohn AC, Farley M, et al. Current epidemiology and trends in invasive Haemophilus influenzae disease — United States, 1989-2008. Clin Infect Dis. 2011;53:1230-6.
• Wang X, Mair R, Hatcher C, et al. Detection of bacterial pathogens in Mongolia meningitis surveillance with a new real-time PCR assay to detect Haemophilus influenzae. Int J Med Microbiol. 2011;301:303-309.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2010.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2009.
• Erwin AL, Sandstedt SA, Bonthuis PJ, et al. Analysis of genetic relatedness of Haemophilus influenzae isolates by multilocus sequence typing. J Bacteriol. 2008;190(4):1473-83.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2008.
• Centers for Disease Control and Prevention. Update: Continued Haemophilus influenzae type b vaccine shortage and surveillance for invasive influenzae disease — United States, 2007-2008. MMWR Morb Mortal Wkly Rep. 2008;57(46);1252-5.
• Satola SW, Napier B, Farley MM. Association of IS1016 with the hia adhesion gene and biotype V and I in invasive nontypeable Haemophilus influenzae. Infect Immun. 2008;76(11):5221-7.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2007.
• Satola SW, Collins JT, Napier R, Farley MM. Capsule gene analysis of invasive Haemophilus influenzae: accuracy of serotyping and prevalence of IS1016 among nontypeable isolates. J Clin Microbiol. 2007;45(10):3230-8.
• Triden L, Glennen A, Juni B, Lynfield R. Invasive Haemophilus influenzae disease and antibiotic susceptibility of invasive isolates in Minnesota, 2002-2005. Infect Dis Clin Pract. 2007;15(6):373-6.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2006.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2005.
• Kapogiannis BG, Satola S, Keyserling HL, Farley MM. Invasive Infections with influenzae serotype a containing an IS 1016-bexA partial deletion: Possible association with virulence. Clin Infect Dis. 2005;41:e97-103.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2004.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2003.
• LaClaire LL, Tondella MLC, Beall DS, et al. Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing. J Clin Microbiol. 2003;41:1:393-6.
• Centers for Disease Control and Prevention. 2002. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2002.
• Ohuabunwo C, Bath S, Bisgard K, Murphy T, Shutt K, Rosenstein N. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children, United States, 1998-2000. MMWR Morb Mortal Wkly Rep. 2002;51(11);234-7.
• Raghunathan PL, LaClaire LL, Tondella ML, et al. Serotyping discrepancies in Haemophilus influenzae type b disease, United States, 1998-1999. MMWR Morb Mortal Wkly Rep. 2002;51(32);706-7.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2001.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2000.

 Top of Page

1995-1999:

• Centers for Disease Control and Prevention. Achievements in public health, 1900-1999: Impact of vaccines universally recommended for children – United States, 1990-1999. MMWR Morb Mortal Wkly Rep. 1999;48(12);243-8.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1999.
• Jafari HS, Adams WG, Robinson KA, Plikaytis BD, Wenger JD. Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. The Haemophilus Influenzae Study Group. Am J Public Health. 1999;89:364-8.
• Bisgard K, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Haemophilus influenzae disease in the United States, 1994-1995: Near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis. 1998;4:229-37.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1998.
• Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children — United States, 1987-1997. MMWR Morb Mortal Wkly Rep. 1998;47:993-8.
• Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1997.
• Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children — United States, 1987-1995. MMWR Morb Mortal Wkly Rep. 1996;45(42):901-6.
• Urwin G, Krohn JA, Deaver-Robinson K, Wenger JD, Farley MM, and the Influenzae study group. Invasive Haemophilus influenzae serotype f disease: Clinical and epidemiological characteristics in the Hib vaccine era. Clin Infect Dis. 1996;22:1069-76.
• Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children-United States, 1993-1994. MMWR Morb Mortal Wkly Rep. 1995;44(29):545-50.

 Top of Page

1988 – 1994:

• Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children–United States, 1987-1993. MMWR Morb Mortal Wkly Rep. 1994;43(8):144-8.
• Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269:221-6.
• Farley MM, Stephens DS, Brachman PS Jr, Harvey RC, Smith JD, Wenger JD. Invasive Haemophilus influenzae disease in adults: Population-based surveillance. Ann Intern Med. 1992;116:806-12.
• Farley MM, Stephens DS, Harvey RC, Sikes RK, Wenger JD, and the CDC Meningitis Surveillance Group. Incidence and clinical characteristics of invasive Haemophilus influenzae in adults. J Infect Dis. 1992;165:S42-3.
• Wenger JD, Pierce R, Deaver K, et al. Invasive Haemophilus influenzae disease: A population-based evaluation of the role of capsular polysaccharide serotype. J Infect Dis. 1992;165 [Suppl. 1]:S34-5.
• Wenger JD, Pierce R, Deaver KA, et al. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Lancet. 1991;338:395-8.
• Wenger JD, Harrison LH, Hightower A, Broome CV. Day care characteristics associated with Haemophilus influenzae Am J Public Health. 1990;80:1455-8.
• Harrison LH, Broome CV, Hightower AW. Haemophilus influenzae type b polysaccharide vaccine: an efficacy study. Pediatrics. 1989;84:255-61.
• Harrison LH, Broome CV, Hightower AW, et al. A day care-based study of the efficacy of Haemophilus b polysaccharide vaccine. JAMA. 1988;260:1413-8.

 Top of Page